News in the Life Sciences Industry

Leading oncology decision support tool to unveil new branding at Oncology Clinical Pathways Congress

DUBLIN, Oct. 11, 2019 /PRNewswire/ -- The Read more ››

CHICAGO, Oct. 11, 2019 /PRNewswire/ -- Specialdocs Consultants, a pioneer in concierge medicine transitions and ongoing management, announces two key appointments to its executive team: Dave Farr as vice president of business development and Shirin Zarinkia as vice president of strategy.

DANA POINT, Calif., Oct. 11, 2019 /PRNewswire/ -- A recent report from the California Department of Health reported alarming news about the opioid crisis, specifically fatal overdoses from the synthetic opioid drug, fentanyl. In the past 4 years, fentanyl overdose deaths have skyrocketed 614%... Read more ››

WOBURN, Mass., Oct. 11, 2019 /PRNewswire/ -- Agrivida, a privately held biotechnology company, today announces the appointment of board member Rajiv Singh as interim CEO with the departure of current CEO Dan Meagher. Meagher has accepted an executive position with a global animal health and nutrition... Read more ››

MUMBAI, Oct. 11, 2019 /PRNewswire/ -- Johnson & Johnson today announced it has committed to ensuring more than $500 million is dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts to eliminate HIV and tuberculosis... Read more ››

OSAKA, Japan, Oct. 11, 2019 /PRNewswire/ -- Shionogi & Co., Ltd. (Head Office: Osaka; President and CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announced that it has entered into a new license agreement with Hsiri Therapeutics, Inc. (Head Office: Media, PA, USA; President and... Read more ››

LUND, Sweden, Oct. 11, 2019 /PRNewswire/ -- Hansa Biopharma will publish its interim report for the first nine months of 2019 at 8:00 a.m. CET on October 31, 2019. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results... Read more ››

SAN FRANCISCO and SAN MATEO, Calif., Oct. 11, 2019 /PRNewswire/ -- Altais, in collaboration with Blue Shield of California, today announced a partnership with Read more ››

SAN JOSE, Calif., Oct. 11, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that it has appointed Paul... Read more ››

PALO ALTO, Calif., Oct. 11, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD) will host an R&D Day in San Francisco to highlight significant progress in the development of its lead therapeutic candidate KSI-301. The R&D event, including a live video stream, will be held on Monday,... Read more ››

Multiple Trials Illustrate the Significant Clinical Benefit of MolecuLight's Point-of-Care
Fluorescence Imaging Device for Chronic Wound Management

EDEN PRAIRIE, Minn., Oct. 10, 2019 /PRNewswire/ -- MIVI Neuroscience, Inc. today announced the appointment of Fred Moll, MD as Chairman of its Board of Directors.

TEL AVIV, Israel, Oct. 10, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today an update on its planned merger with... Read more ››

DUBLIN, Oct. 10, 2019 /PRNewswire/ -- The Read more ››

PALO ALTO, Calif., Oct. 10, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, announced that the first patients have been treated in the DAZZLE pivotal study... Read more ››